Brief: Klaria Receives SEK 2.6 Mln Funding
March 1 (Reuters) - Klaria Pharma Holding AB (publ) KLAR.ST :
* RECEIVES 2,6 MSEK PAYMENT FROM IMBRIUM THERAPEUTICS IN THE EPINEPHRINE ALGINATE FILM
RESEARCH
AND DEVELOPMENT COLLABORATION
* RECEIVED ADDITIONAL FUNDING FROM ITS PARTNER IMBRIUM THERAPEUTICS TO FUND ADDITIONAL
RESEARCH IN
EPINEPHRINE ALGINATE FILM COLLABORATION
Source text for Eikon: ID:nWkrc3KDlT
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement